Skip to main content
Erschienen in: World Journal of Urology 2/2012

01.04.2012 | Original Article

Surgical margin status of specimen and oncological outcomes after laparoscopic radical prostatectomy: experience after 400 procedures

verfasst von: Francesco Porpiglia, Cristian Fiori, Matteo Manfredi, Susanna Grande, Massimiliano Poggio, Enrico Bollito, Mauro Papotti, Roberto Mario Scarpa

Erschienen in: World Journal of Urology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyse the surgical margins status of prostatic glands, resected by laparoscopic radical prostatectomy (LRP) for prostate cancer, and to correlate it with biochemical free survival rate (BFSR).

Methods

Data were collected prospectively from 405 patients undergoing LRP from 2000 to 2009 at a single institution. Patients undergoing neoadjuvant and/or adjuvant therapy were excluded from the study. Three hundred patients matched all the criteria: 232 of these had negative surgical margins (NSM) and 68 positive surgical margins (PSM). The median follow-up was 62 months. PSM were classified based on the following: (a) the number of margins, monofocal and multifocal, (b) the location, apical or non-apical and (c) the extension, ≤2.8 mm or >2.8 mm. These data were then entered into a multivariate analysis.

Results

Overall BFSR rate was 67.6% in PSM group and 88.8% in NSM group (P < 0.001). We registered a HR of 3.78 in multivariate analysis (P < 0.001). In terms of the extension, BFSR in univariate survival analysis was 77.8% in ≤2.8 mm PSM and 38.9% in >2.8 mm PSM (P = 0.003), with a HR of 5.68 (P = 0.011) in multivariate analysis. BFSR was 59% for apical margins and 77% for non-apical margins (P = 0.038). In monofocal margins, BFSR was 73%, while 53% in multifocal (P = 0.014).

Conclusions

We recommend careful evaluation of patients with PSM following LRP, especially if they are more than 2.8 mm, and in these cases, adjuvant therapy should be considered after radical surgery.
Literatur
1.
Zurück zum Zitat Wright JL, Dalkin BL, True LD et al (2010) Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol 183(6):2213–2218PubMedCrossRef Wright JL, Dalkin BL, True LD et al (2010) Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol 183(6):2213–2218PubMedCrossRef
2.
Zurück zum Zitat Grossfeld GD, Chang JJ, Broering JM et al (2000) Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. Urology 163(4):1171–1177CrossRef Grossfeld GD, Chang JJ, Broering JM et al (2000) Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. Urology 163(4):1171–1177CrossRef
3.
Zurück zum Zitat Blute ML, Bostwick DG, Bergstralh EJ et al (1997) Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 50(5):733–739PubMedCrossRef Blute ML, Bostwick DG, Bergstralh EJ et al (1997) Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 50(5):733–739PubMedCrossRef
4.
Zurück zum Zitat Karakiewicz PI, Eastham JA, Graefen M et al (2005) Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 66(6):1245–1250PubMedCrossRef Karakiewicz PI, Eastham JA, Graefen M et al (2005) Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 66(6):1245–1250PubMedCrossRef
5.
Zurück zum Zitat Swindle P, Eastham JA, Ohori M et al (2005) Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 174(3):903–907PubMedCrossRef Swindle P, Eastham JA, Ohori M et al (2005) Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 174(3):903–907PubMedCrossRef
6.
Zurück zum Zitat Fesseha T, Sakr W, Grignon D et al (1997) Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol 158(6):2176–2179PubMedCrossRef Fesseha T, Sakr W, Grignon D et al (1997) Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol 158(6):2176–2179PubMedCrossRef
7.
Zurück zum Zitat Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM (1999) Biological determinants of cancer progression in men with prostate cancer. JAMA 281(15):1395–1400PubMedCrossRef Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM (1999) Biological determinants of cancer progression in men with prostate cancer. JAMA 281(15):1395–1400PubMedCrossRef
8.
Zurück zum Zitat Vis AN, Schröder FH, van der Kwast TH (2006) The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 50(2):258–265PubMedCrossRef Vis AN, Schröder FH, van der Kwast TH (2006) The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 50(2):258–265PubMedCrossRef
9.
Zurück zum Zitat Porpiglia F, Terrone C, Tarabuzzi R et al (2006) Transperitoneal versus extraperitoneal laparoscopic radical prostatectomy: experience of a single center. Urology 68(2):376–380PubMedCrossRef Porpiglia F, Terrone C, Tarabuzzi R et al (2006) Transperitoneal versus extraperitoneal laparoscopic radical prostatectomy: experience of a single center. Urology 68(2):376–380PubMedCrossRef
10.
Zurück zum Zitat Montironi R, Mazzucchelli R, Kwast T (2003) Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance. Virchows Arch 442(3):211–217PubMed Montironi R, Mazzucchelli R, Kwast T (2003) Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance. Virchows Arch 442(3):211–217PubMed
11.
Zurück zum Zitat Cookson MS, Aus G, Burnett AL et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American urological association prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177(2):540–544PubMedCrossRef Cookson MS, Aus G, Burnett AL et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American urological association prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177(2):540–544PubMedCrossRef
12.
Zurück zum Zitat Stephenson AJ, Wood DP, Kattan MW et al (2009) Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J Urol 182(4):1357–1363PubMedCrossRef Stephenson AJ, Wood DP, Kattan MW et al (2009) Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J Urol 182(4):1357–1363PubMedCrossRef
13.
Zurück zum Zitat Salomon L, Anastasiadis A, Evrel O et al (2003) Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer. Urology 61(2):386–390PubMedCrossRef Salomon L, Anastasiadis A, Evrel O et al (2003) Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer. Urology 61(2):386–390PubMedCrossRef
14.
Zurück zum Zitat Kausik SJ, Blute ML, Sebo TJ et al (2002) Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy cancer. Cancer 95(6):1215–1219PubMedCrossRef Kausik SJ, Blute ML, Sebo TJ et al (2002) Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy cancer. Cancer 95(6):1215–1219PubMedCrossRef
15.
Zurück zum Zitat Ochiai A, Sotelo T, Troncoso P, Bhadkamkar V, Babaian RJ (2008) Natural history of biochemical progression after radical prostatectomy based on length of a positive margin. Urology 71(2):308–312PubMedCrossRef Ochiai A, Sotelo T, Troncoso P, Bhadkamkar V, Babaian RJ (2008) Natural history of biochemical progression after radical prostatectomy based on length of a positive margin. Urology 71(2):308–312PubMedCrossRef
16.
Zurück zum Zitat Kordan Y, Salem S, Chang SS et al (2009) Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy. J Urol 182(6):2695–2701PubMedCrossRef Kordan Y, Salem S, Chang SS et al (2009) Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy. J Urol 182(6):2695–2701PubMedCrossRef
17.
Zurück zum Zitat van Oort IM, Bruins HM, Kiemeney LALM, Knipscheer BC, Witjes JA, Hulsbergen-van de Kaa CA (2010) The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy. Histopathology 56(4):464–471PubMedCrossRef van Oort IM, Bruins HM, Kiemeney LALM, Knipscheer BC, Witjes JA, Hulsbergen-van de Kaa CA (2010) The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy. Histopathology 56(4):464–471PubMedCrossRef
18.
Zurück zum Zitat Babaian RJ, Troncoso P, Bhadkamkar V, Johnston DA (2001) Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer 91(8):1414–1422PubMedCrossRef Babaian RJ, Troncoso P, Bhadkamkar V, Johnston DA (2001) Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer 91(8):1414–1422PubMedCrossRef
Metadaten
Titel
Surgical margin status of specimen and oncological outcomes after laparoscopic radical prostatectomy: experience after 400 procedures
verfasst von
Francesco Porpiglia
Cristian Fiori
Matteo Manfredi
Susanna Grande
Massimiliano Poggio
Enrico Bollito
Mauro Papotti
Roberto Mario Scarpa
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 2/2012
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-011-0711-2

Weitere Artikel der Ausgabe 2/2012

World Journal of Urology 2/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.